Literature DB >> 25894409

Reply to Letter: "Infusion of CD133+ Bone Marrow-Derived Stem Cell After Selective Portal Vein Embolization Enhances Functional Hepatic Reserves After Extended Right Hepatectomy".

Jan Schulte am Esch1, Moritz Schmelzle, Constanze Duhme, Guenter Fuerst, Simon C Robson, Johannes G Bode, Andreas Krieg, Stefan A Topp, Dieter Haeussinger, Wolfram T Knoefel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 25894409      PMCID： PMC4609212          DOI： 10.1097/SLA.0000000000000849

Source DB:  PubMed          Journal:  Ann Surg        ISSN： 0003-4932            Impact factor:   12.969


× No keyword cloud information.
  7 in total

1.  Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration.

Authors:  Jan Schulte am Esch; Wolfram Trudo Knoefel; Michael Klein; Ali Ghodsizad; Guenter Fuerst; Ludger W Poll; Christoph Piechaczek; Elmar R Burchardt; Niko Feifel; Volker Stoldt; Marcus Stockschläder; Nikolas Stoecklein; Roy Y Tustas; Claus F Eisenberger; Matthias Peiper; Dieter Häussinger; Stefan B Hosch
Journal:  Stem Cells       Date:  2005-04       Impact factor: 6.277

2.  Stem cell therapy for chronic liver disease--choosing the right tools for the job.

Authors:  Stuart J Forbes
Journal:  Gut       Date:  2008-02       Impact factor: 23.059

3.  In situ liver transection with portal vein ligation for rapid growth of the future liver remnant in two-stage liver resection.

Authors:  W T Knoefel; I Gabor; A Rehders; A Alexander; M Krausch; J Schulte am Esch; G Fürst; S A Topp
Journal:  Br J Surg       Date:  2012-11-02       Impact factor: 6.939

4.  Infusion of CD133+ bone marrow-derived stem cells after selective portal vein embolization enhances functional hepatic reserves after extended right hepatectomy: a retrospective single-center study.

Authors:  Jan Schulte am Esch; Moritz Schmelzle; Günther Fürst; Simon C Robson; Andreas Krieg; Constanze Duhme; Roy Y Tustas; Andrea Alexander; Hans M Klein; Stefan A Topp; Johannes G Bode; Dieter Häussinger; Claus F Eisenberger; Wolfram Trudo Knoefel
Journal:  Ann Surg       Date:  2012-01       Impact factor: 12.969

5.  CD39 modulates hematopoietic stem cell recruitment and promotes liver regeneration in mice and humans after partial hepatectomy.

Authors:  Jan Schulte Am Esch; Simon C Robson; Moritz Schmelzle; Constanze Duhme; Wolfgang Junger; Steven D Salhanick; Yu Chen; Yan Wu; Vasilis Toxavidis; Eva Csizmadia; Lihui Han; Shu Bian; Günter Fürst; Martina Nowak; Seth J Karp; Wolfram T Knoefel
Journal:  Ann Surg       Date:  2013-04       Impact factor: 12.969

6.  Human mesenchymal stem cells as a two-edged sword in hepatic regenerative medicine: engraftment and hepatocyte differentiation versus profibrogenic potential.

Authors:  L Valfrè di Bonzo; I Ferrero; C Cravanzola; K Mareschi; D Rustichell; E Novo; F Sanavio; S Cannito; E Zamara; M Bertero; A Davit; S Francica; F Novelli; S Colombatto; F Fagioli; M Parola
Journal:  Gut       Date:  2007-07-16       Impact factor: 23.059

7.  Portal vein embolization vs. portal vein ligation for induction of hypertrophy of the future liver remnant.

Authors:  Dieter C Broering; Christian Hillert; Gerrit Krupski; Lutz Fischer; Lars Mueller; Eike G Achilles; Jan Schulte am Esch; Xavier Rogiers
Journal:  J Gastrointest Surg       Date:  2002 Nov-Dec       Impact factor: 3.267
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.